vs

Side-by-side financial comparison of MEDIFAST INC (MED) and REPUBLIC BANCORP INC (RBCAA). Click either name above to swap in a different company.

REPUBLIC BANCORP INC is the larger business by last-quarter revenue ($94.3M vs $75.1M, roughly 1.3× MEDIFAST INC). On growth, REPUBLIC BANCORP INC posted the faster year-over-year revenue change (5.3% vs -36.9%). REPUBLIC BANCORP INC produced more free cash flow last quarter ($161.1M vs $-6.6M). Over the past eight quarters, REPUBLIC BANCORP INC's revenue compounded faster (-11.5% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Republic Bancorp Inc. (Kentucky) is a U.S. regional banking holding company that provides a full range of retail and commercial banking services, including personal deposit accounts, consumer loans, business financing, mortgage products, and wealth management solutions. It mainly serves individual consumers and small to medium-sized enterprises in Kentucky and adjacent U.S. states.

MED vs RBCAA — Head-to-Head

Bigger by revenue
RBCAA
RBCAA
1.3× larger
RBCAA
$94.3M
$75.1M
MED
Growing faster (revenue YoY)
RBCAA
RBCAA
+42.2% gap
RBCAA
5.3%
-36.9%
MED
More free cash flow
RBCAA
RBCAA
$167.7M more FCF
RBCAA
$161.1M
$-6.6M
MED
Faster 2-yr revenue CAGR
RBCAA
RBCAA
Annualised
RBCAA
-11.5%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
RBCAA
RBCAA
Revenue
$75.1M
$94.3M
Net Profit
$22.8M
Gross Margin
69.4%
Operating Margin
-10.4%
29.3%
Net Margin
24.2%
Revenue YoY
-36.9%
5.3%
Net Profit YoY
20.0%
EPS (diluted)
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
RBCAA
RBCAA
Q4 25
$75.1M
$94.3M
Q3 25
$89.4M
$93.5M
Q2 25
$105.6M
$93.8M
Q1 25
$115.7M
$135.8M
Q4 24
$119.0M
$89.5M
Q3 24
$140.2M
$88.1M
Q2 24
$168.6M
$86.9M
Q1 24
$174.7M
$120.3M
Net Profit
MED
MED
RBCAA
RBCAA
Q4 25
$22.8M
Q3 25
$-2.3M
$29.7M
Q2 25
$2.5M
$31.5M
Q1 25
$-772.0K
$47.3M
Q4 24
$19.0M
Q3 24
$1.1M
$26.5M
Q2 24
$-8.2M
$25.2M
Q1 24
$8.3M
$30.6M
Gross Margin
MED
MED
RBCAA
RBCAA
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
RBCAA
RBCAA
Q4 25
-10.4%
29.3%
Q3 25
-4.6%
40.4%
Q2 25
-1.0%
43.0%
Q1 25
-1.1%
44.1%
Q4 24
0.6%
25.8%
Q3 24
1.5%
38.4%
Q2 24
-4.7%
37.0%
Q1 24
4.5%
32.2%
Net Margin
MED
MED
RBCAA
RBCAA
Q4 25
24.2%
Q3 25
-2.5%
31.8%
Q2 25
2.3%
33.5%
Q1 25
-0.7%
34.8%
Q4 24
21.2%
Q3 24
0.8%
30.1%
Q2 24
-4.8%
29.0%
Q1 24
4.8%
25.4%
EPS (diluted)
MED
MED
RBCAA
RBCAA
Q4 25
$-1.64
Q3 25
$-0.21
Q2 25
$0.22
Q1 25
$-0.07
Q4 24
$0.08
Q3 24
$0.10
Q2 24
$-0.75
Q1 24
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
RBCAA
RBCAA
Cash + ST InvestmentsLiquidity on hand
$167.3M
$220.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$1.1B
Total Assets
$248.0M
$7.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
RBCAA
RBCAA
Q4 25
$167.3M
$220.0M
Q3 25
$173.5M
$484.2M
Q2 25
$162.7M
$484.8M
Q1 25
$164.6M
$793.0M
Q4 24
$162.3M
$432.2M
Q3 24
$170.0M
$530.9M
Q2 24
$163.5M
$400.1M
Q1 24
$156.4M
$546.4M
Stockholders' Equity
MED
MED
RBCAA
RBCAA
Q4 25
$198.9M
$1.1B
Q3 25
$214.7M
$1.1B
Q2 25
$216.0M
$1.1B
Q1 25
$211.0M
$1.0B
Q4 24
$210.1M
$992.0M
Q3 24
$207.3M
$979.7M
Q2 24
$205.3M
$955.4M
Q1 24
$211.0M
$935.6M
Total Assets
MED
MED
RBCAA
RBCAA
Q4 25
$248.0M
$7.0B
Q3 25
$268.2M
$7.0B
Q2 25
$269.3M
$7.0B
Q1 25
$280.0M
$7.1B
Q4 24
$284.2M
$6.8B
Q3 24
$291.2M
$6.7B
Q2 24
$293.5M
$6.6B
Q1 24
$302.8M
$6.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
RBCAA
RBCAA
Operating Cash FlowLast quarter
$-5.3M
$168.2M
Free Cash FlowOCF − Capex
$-6.6M
$161.1M
FCF MarginFCF / Revenue
-8.8%
170.9%
Capex IntensityCapex / Revenue
1.8%
7.5%
Cash ConversionOCF / Net Profit
7.37×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$288.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
RBCAA
RBCAA
Q4 25
$-5.3M
$168.2M
Q3 25
$12.1M
$33.3M
Q2 25
$-3.4M
$8.4M
Q1 25
$3.4M
$93.2M
Q4 24
$-4.9M
$149.0M
Q3 24
$9.1M
$51.3M
Q2 24
$13.1M
$4.0M
Q1 24
$7.3M
$71.2M
Free Cash Flow
MED
MED
RBCAA
RBCAA
Q4 25
$-6.6M
$161.1M
Q3 25
$10.8M
$30.8M
Q2 25
$-4.8M
$5.2M
Q1 25
$1.9M
$91.6M
Q4 24
$-7.2M
$143.2M
Q3 24
$7.7M
$49.8M
Q2 24
$11.1M
$2.7M
Q1 24
$5.4M
$69.1M
FCF Margin
MED
MED
RBCAA
RBCAA
Q4 25
-8.8%
170.9%
Q3 25
12.0%
32.9%
Q2 25
-4.5%
5.5%
Q1 25
1.6%
67.4%
Q4 24
-6.1%
160.0%
Q3 24
5.5%
56.5%
Q2 24
6.6%
3.1%
Q1 24
3.1%
57.5%
Capex Intensity
MED
MED
RBCAA
RBCAA
Q4 25
1.8%
7.5%
Q3 25
1.5%
2.6%
Q2 25
1.3%
3.5%
Q1 25
1.3%
1.2%
Q4 24
1.9%
6.5%
Q3 24
1.0%
1.7%
Q2 24
1.1%
1.5%
Q1 24
1.1%
1.7%
Cash Conversion
MED
MED
RBCAA
RBCAA
Q4 25
7.37×
Q3 25
1.12×
Q2 25
-1.36×
0.27×
Q1 25
1.97×
Q4 24
7.84×
Q3 24
8.04×
1.93×
Q2 24
0.16×
Q1 24
0.88×
2.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons